ICU Medical Inc – FDA 483, Sep 20, 2024
ICU Medical Inc. received a Form 483 citing ten observations primarily related to quality control, stability testing, and laboratory practices. Deficiencies included inadequate document control, unapproved logbooks, issues with stability study execution and environmental monitoring, and failures in microbiological contamination prevention. The firm also lacked thorough investigation procedures for out-of-specification results, had deficiencies in laboratory instrument qualification, and failed to comply with Drug Supply Chain Security Act verification requirements.
ID · 5db0b0cd-f781-4a32-aeac-1f4460f82c3a
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.